---
document_datetime: 2023-09-21 19:55:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/dificlir-epar-all-authorised-presentations_en.pdf
document_name: dificlir-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8724453
conversion_datetime: 2025-12-22 12:16:59.412859
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form          | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size                   |
|------------------|-------------------|------------|------------------------------|---------------------------|-----------------------|---------------------------|-----------------------------|
| EU/1/11/733/003  | Dificlir          | 200 mg     | Film-coated tablet           | Oral use                  | blister (alu/alu)     |                           | 100 x 1 tablets (unit dose) |
| EU/1/11/733/004  | Dificlir          | 200 mg     | Film-coated tablet           | Oral use                  | blister (alu/alu)     |                           | 20 x 1 tablets (unit dose)  |
| EU/1/11/733/005  | Dificlir          | 40 mg/ml   | Granules for oral suspension | Oral use                  | bottle (glass)        | 7.7 g                     | 1 bottle                    |